Researchers are turning to computational models to solve some of the most pressing biomedical challenges. Melding the intricacies of human biological systems with the precision …
The FY2024 Consolidated Appropriations Act was passed in two parts during March. These bills, along with the accompanying reports, contain provisions that support human-relevant research …
Beagles made headlines in 2022 when 4000 of them were rescued from the Envigo breeding and research facility. The facility was found to have dozens …
NAMs is a common acronym used to represent human biology-based methods in biomedical research. This acronym often refers to human-relevant testing methods like organ chips, …
In the United States alone, COVID-19 erased two decades of life expectancy growth. The U.S. also ranks lowest in life expectancy for both men and …
For decades, animal experimentation was considered the “gold standard” of biomedical research, but today a growing number of well-known scientists and researchers begin to challenge …
In the wake of a global pandemic, Dystopian films depicting rampant disease leading to the end of the world take on a new patina of …
CEO and Co-founder of the Center for Contemporary Sciences, Dr. Aysha Akhtar M.D., M.P.H., was interviewed by Dr. Erika Gebel Berg Ph.D., Director and Science …
COVID-19 changed lives. We lost loved ones and missed out on moments like weddings and graduations. Since March 2020, the term “once in a lifetime” …
In the article Human disease models in drug development published in Nature, the authors delve into the critical role of human disease models in drug …
In December 2022, the FDA Modernization Act 2.0 was passed by Congress as part of the FY2023 Omnibus bill. The FDA Modernization Act updated the …
Originally appeared in Clinical Leader: Alternatives To Animal Testing In Preclinical Research (clinicalleader.com) I’m a doctor, but I hate wearing my car seat belt. And …
CCS is a nonprofit 501(c)(3) organization. Contributions to CCS are tax deductible to the extent permitted by law. EIN 84-3817744